Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
A
Details...
Enter Symbol
Neurocrine Biosciences, Inc. (NASDAQ: NBIX)
Sector: Medical
Current Price :
$6.47
52 Week Low
$5.50
52 Week High
$9.79
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
66M
Market Cap:
$0.47B
Avg Volume:
460424
P/E Ratio:
11.540
PEG Ratio:
-0.010
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
Neurocrine Biosciences (NBIX) Pipeline Will Drive Upside In 2012, Initiated As 'Buy': Deutsche Bank
Mar 17, 2012 02:08 PM |
NBIX
Sector Detector: Bulls Sucking Wind In Late Push To Close Year Positive
Dec 29, 2011 01:29 PM |
AAPL
,
NBIX
,
NZT
,
ORCL
,
UTHR
What US Debt Default Talk Means For The Stock Market - Mike Swanson (07/25/11)
Jul 26, 2011 01:38 AM |
NBIX
Bears On The Run
May 31, 2011 07:50 PM |
AAPL
,
AMZN
,
ASH
,
FCEL
,
FTWR
,
GS
Indices Snapback From Morning Losses To Close Positive
Nov 10, 2010 07:54 PM |
AAPL
,
ADAM
,
AFOP
,
APKT
,
APSG
,
BEXP
More Articles on NBIX..
Market News
More News on NBIX..
Press Releases
Neurocrine Biosciences Announces Urocortin 2 Phase II Study Results in Patients With Acute Decompensated Heart Failure
May 17, 2012 04:05 PM |
NBIX
Neurocrine Biosciences To Present At The Deutsche Bank 37th Annual Health Care Conference
May 04, 2012 02:21 PM |
NBIX
Neurocrine Biosciences Reports First Quarter 2012 Results
May 02, 2012 04:05 PM |
NBIX
More Press Releases on NBIX..
SEC Filings
Form 4 NEUROCRINE BIOSCIENCES For: Feb 09 Filed by: LAMPERT MARK N (10K)
Feb 10, 2012 06:17 PM
Form 4 NEUROCRINE BIOSCIENCES For: Oct 12 Filed by: LAMPERT MARK N (10K)
Oct 14, 2011 04:20 PM
Form 4 NEUROCRINE BIOSCIENCES For: Oct 10 Filed by: LAMPERT MARK N (10K)
Oct 12, 2011 05:17 PM
More SEC Filings on NBIX..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
NBIX
Compare to S&P
YTD
-17.18 %
-26.51 %
4 Weeks
-6.51 %
-5.65 %
12 Weeks
-19.73 %
-20.77 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-150.00 %
EPS Growth in Last Year:
-120.00 %
Sales Growth in Last Quarter:
1.41 %
Sales Growth in Last Quarter:
-9.95 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##